Intraoperative Intraperitoneal Chemoperfusion to Treat Peritoneal Minimal Residual Disease in Stage III Ovarian Cancer

NCT02567253 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer
Primary Peritoneal Cancer

Interventions

PROCEDURE: Cytoreductive surgery
DRUG: IPEC with Cisplatin (75mg/m²)
DRUG: IPEC with Cisplatin (100mg/m²)
DRUG: Hypertherm IntraPEritoneal Chemotherapy with Cisplatin (75mg/m²)
DRUG: HIPEC with Cisplatin (100mg/m²)

Sponsor

University Hospital, Ghent